Combined use of recombinant activated factor VII and ECMO in severe postoperative bleeding after cardiac surgery in a newborn: death due to ventricular dysfunction

Klin Padiatr. 2012 Apr;224(3):193-4. doi: 10.1055/s-0032-1308984. Epub 2012 Apr 13.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / etiology
  • Cardiopulmonary Bypass*
  • Cause of Death
  • Chest Tubes
  • Combined Modality Therapy
  • Extracorporeal Membrane Oxygenation*
  • Factor VIIa / therapeutic use*
  • Fatal Outcome
  • Heart Ventricles / pathology
  • Humans
  • Infant, Newborn
  • Ischemia / pathology
  • Multiple Organ Failure / etiology*
  • Multiple Organ Failure / pathology
  • Necrosis
  • Off-Label Use
  • Postoperative Complications / etiology*
  • Postoperative Complications / pathology
  • Postoperative Hemorrhage / pathology
  • Postoperative Hemorrhage / therapy*
  • Recombinant Proteins / therapeutic use
  • Transposition of Great Vessels / pathology
  • Transposition of Great Vessels / surgery*
  • Ventricular Dysfunction, Left / etiology*
  • Ventricular Dysfunction, Left / pathology

Substances

  • Recombinant Proteins
  • recombinant FVIIa
  • Factor VIIa